{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20250812",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "83098",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/216956Orig1s002ltr.pdf",
              "date": "20250813",
              "type": "Letter"
            },
            {
              "id": "83102",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216956s002lbl.pdf",
              "date": "20250815",
              "type": "Label"
            },
            {
              "id": "83103",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216956s002lbl.pdf#page=25",
              "date": "20250815",
              "type": "Medication Guide"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20240605",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "78657",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216956s001lbl.pdf",
              "date": "20240606",
              "type": "Label"
            },
            {
              "id": "78734",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/216956Orig1s001ltr.pdf",
              "date": "20240702",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20231012",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "75724",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216956s000lbl.pdf",
              "date": "20231013",
              "type": "Label"
            },
            {
              "id": "75725",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216956s000lbl.pdf#page=24",
              "date": "20231013",
              "type": "Medication Guide"
            },
            {
              "id": "75729",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/216956Orig1s000ltr.pdf",
              "date": "20231013",
              "type": "Letter"
            },
            {
              "id": "76566",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/216956Orig1s000TOC.html",
              "date": "20231114",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA216956",
      "sponsor_name": "PFIZER",
      "openfda": {
        "application_number": [
          "NDA216956"
        ],
        "brand_name": [
          "VELSIPITY"
        ],
        "generic_name": [
          "ETRASIMOD"
        ],
        "manufacturer_name": [
          "Pfizer Laboratories Div Pfizer Inc",
          "U.S. Pharmaceuticals"
        ],
        "product_ndc": [
          "0069-0274",
          "63539-274"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ETRASIMOD ARGININE"
        ],
        "rxcui": [
          "2668051",
          "2668057"
        ],
        "spl_id": [
          "c2b3ca10-be3d-4c1c-b210-9ebefc065826",
          "e566a7bd-2d3f-40f6-afc8-b2b24f563530"
        ],
        "spl_set_id": [
          "65171e4a-d136-4abc-b08c-c40c1b486ff6",
          "d5b2a717-1b5c-4aed-a69c-64a0c4561c40"
        ],
        "package_ndc": [
          "0069-0274-30",
          "63539-274-28",
          "63539-274-30"
        ],
        "unii": [
          "MXE5EMA09L"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "VELSIPITY",
          "active_ingredients": [
            {
              "name": "ETRASIMOD ARGININE",
              "strength": "EQ 2MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}